(Q46194526)

English

Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

feasibility study

1 reference

based on heuristic

inferred from title

immunosuppression

1 reference

based on heuristic

inferred from title

author name string

B Horn

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

S Soni

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

S Khan

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

A Petrovic

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

N Breslin

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

M Cowan

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

G Pelle-Day

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

E Cooperstein

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

L-A Baxter-Lowe

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

language of work or name

0 references

publication date

27 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

43

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

469-476

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

https://scigraph.springernature.com/pub.10.1038/bmt.2008.339

0 references

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

21 January 2018

Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

21 January 2018

Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

21 January 2018

Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and non-myeloablative stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

21 January 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

21 January 2018

Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

21 January 2018

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

Prompt initiation of immunotherapy in children with an increasing number of autologous cells after allogeneic HCT can induce complete donor-type chimerism: a report of 14 children

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring of lineage-specific chimaerism allows early prediction of response following donor lymphocyte infusions for relapsed chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimerism does not predict for outcome after alemtuzumab-based conditioning: lineage-specific analysis of chimerism of specific diseases may be more informative

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.339

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2008.339

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/18955982

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46194526&oldid=2099222977"